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Abstract
The past 15 years opened new avenues for retrovirus and retroelement research. Not surprisingly, they stemmed
from essential knowledge collected in the past, which remains the ground of the present and therefore should be
remembered. However, a short supplement of new break-through discoveries and ideas should be recollected.
Using selected examples of recent works, I tried to extend and supplement my original article published in Folia
Biologica (1996).
Retrovirus integration
Having an insight into the molecular events governing
the central process of retrovirus replication cycle repre-
sented by reverse transcription, the question of site spe-
cificity of retrovirus DNA integration became the focus
of interest. In order to introduce the process of retro-
virus integration the main steps involved in its realiza-
tion are briefly summarized (see Figure 1) Viral DNA
synthesized by reverse transcription is recessed at both
ends constituted of long terminal repeats (LTR). Such
cleavage leads to the formation of CA dinucleotide over-
hangs. The next step is accomplished by staggered nick
on host DNA and joining 3’ recessed ends of viral DNA
with 5’ end nucleotides of host cell DNA. The non-com-
plementary dinucleotides AA from the 5’ ends of viral
DNA are then removed and the gaps between protrud-
ing 5’ ends of cleaved host cell DNA are filled by DNA
repair leading to formation of several nucleotide repeats
flanking the integrated provirus [1].
At present, new knowledge about the interaction of
viral integrase with viral DNA has been obtained using
protein crystallography (for references see Li et al.,
2011)[2]. Integrase acts as a tetramer and engages both
viral DNA ends. It triggers formation of recessed end
joining of 3’ end of viral with 5’ end of cell DNA. These
activities depend on a series of cellular factors; one of
them, the lens epithelium-derived growth factor
(LEDGF), targets HIV DNA, preferentially at active tran-
scription units. LEGDF acts as an adaptor equipped with
integrase and chromatin-binding domains. The latter
can be substituted with sequences binding other pro-
teins which lead to preferential provirus targeting to
selected genome regions [3]. Further knowledge of pro-
cesses deciding about provirus positioning in the cell
genome will undoubtedly contribute to designing of safe
retroviral vectors.
There are clear differences in the affinity of retro-
viruses to certain cell genomic regions. ALU/ASV tend
to integrate in GC-rich, preferentially house-keeping
genes [4,5]. A similar situation is encountered in HIV
infection [6]. However, mouse leukemia virus (MLV)
integrates close to gene promoters, which facilitates cell
gene activation [7]. If a protooncogene is activated in
such a way, it can trigger tumor formation, as was docu-
mented in humans infected with MLV-based retroviral
vector resulting in LMO oncogene activation and lym-
phoma formation [8].
Update of retroviral vector construction
Understanding the conditions under which retrovirus
integration can be directed in defined cell genome
regions has a principal significance for construction of
safe and long-term expressed vectors. This goal seems
to be close, but still requires careful testing.
Detailed study of representative retroviruses indicates
that two of them represent the best candidates for vec-
tor construction. The first are lentiviruses, among which
belongs HIV and similar complex viruses isolated from
different mammalian species. These viruses are patho-
genic but not oncogenic. They are equipped with a ser-
ies of accessory genes that also enable their integration
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in non-dividing cells. Not surprisingly, lentiviruses
stripped of their pathogenic sequences were successfully
employed for construction of vectors. It was reported
that they also acted as an efficient tool for gene therapy
of adrenoleukodystrophy (ALD) [9]. ADL is caused by
mutation of a peroxisomal transporter gene and its defi-
ciency leads to demyelination and consequently to the
nervous system dysfunction. The undamaged gene was
transduced by a lentiviral vector to autologous hemato-
poietic stem cells, which were then implanted to ADL
patients. Encouraging results were obtained because
about 10% patients’ granulocytes expressed the trans-
mitted gene for more than two years and the neurologi-
cal function became stabilized. Further good news is
provided by the clonality of the transduced cells, sug-
gesting random vector integration without striking over-
growth of clonal populations, which might signal a
carcinogenic change.
The second candidates for safe vectors are provided by
ALV/ASV avian retroviruses. These retroviruses do not
replicate in mammalian cells, and therefore it is not
required to strip them of replicative genes in order to
prevent their multiplication. Furthermore, ALV
sequences are not homologous to human endogenous
retroviral genomes and therefore there is almost no
chance of their mutual recombination. However, ALV
integrated in mammalian cells are usually underex-
pressed and prone to silencing by methylation. Never-
theless, retroviral vectors can be protected against
silencing by insertion of CpG islands close to their pro-
moter [10]. Such and additional improvements should
increase their chance to become safe candidates for vec-
tor construction.
Retrotransposable elements
Retrotransposable elements, which employ reverse tran-
scription for their genesis and even for their spread
through the genome, became an important issue of
genomics, evolutionary genetics, oncology, and other
fields of general interest.
We now know that more than 45% of our genome
arose by reverse transcription, which includes 8% of
proviral sequences and 18% of mobile LINE elements
that are involved in spreading the gene sequences and
responsible for pseudogene formation. In contrast to
retroviruses LINE elements use as primers for reverse
transcription stretches of oligo-dT. Such dT rich regions
can aneale with with polyA tails of cell RNAs. Therefore
in some cases a mRNA substitutes LINE RNA template
becomes reverse transcribed to DNA constituting
intronless pseudogenes In spite of the fact that LINE are
mostly defective, about hundred LINE copies remain
active and retrotranspose to our genome.
The field of retrotransposable elements had been
reviewed several times in the past, but sophisticated cell
control over these elements was recently summarized by
Goodier and Kazazian, 2008[11]; Blumenstiel, 2011[12].
In order to illustrate some of present-day topics that are
being analyzed in depth, the following three examples
will be shortly discussed (Figure 2).
The first example is represented by PIWI elements,
which spread in Drosophila and rapidly expanded in
mammalian evolution [13]. PIWI spreading is counter-
acted by piRNAs, whose interaction with PIWI proteins
leads to inhibition of PIWI transcription. This process is
even more complicated due to different effects of sense
or antisense piRNA and it can lead to amplification of
signals inhibiting PIWI transcription[14,15] (see Figure
2). Drosophila piRNA clusters were identified as ancient
fragmented transposon copies, however being signifi-
cantly diverged from active retrotransposon sequences
(reviewed in Malone and Hannon, 2009)[16].
The second case (Figure 2) documents how pseudo-
genes can regulate very important tumor suppressor
gene PTEN, which inhibits the oncogene PI3K by
dephosphorylation. PTEN is under the control of small
interfering RNA (siRNA), which down-regulates its
activity. However, such siRNA also binds to the S1
region of 3’ UTR retained in PTEN pseudogenes. In
such a way pseudogenes saturate siRNA and thus
potentiate the activity of the PTEN tumor suppressor
gene [17].
The third example (Figure 2) relates to human endo-
genous retrovirus belonging to the HERV-W family. In
humans there are two members of this family causing
cell fusion resulting in formation of syncytiotrophoblast.
They are called syncytin 1 and 2, both producing retro-
viral glycoprotein responsible for cell fusion. Syncytin 1
(belonging to HERV-W group) is down-regulated in
somatic cells by the lack of splicing resulting in the
absence of viral envelope mRNA and trimethylation of
Figure 1 Scheme of retrovirus integration (modified from Goff
1992)[30]. Note that linear viral DNA integrates in antiparallel host
cell DNA strands. Ends of viral DNA comprising critical part of long
terminal repeats are boxed. N denotes nucleotide- complementary
nucleotide. A full description of integration steps is given in the
text.
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histone 3K9. On the contrary, in trophoblastic cells the
syncytin message is efficiently spliced and methylation is
also changed in favor of the methylation pattern poten-
tiating splicing (H3K36) [18]. This example illustrates
how proviruses can be employed to perform important
functions in the organism and how they become sub-
dued to cell regulation and utilized for new cell
functions.
The already mentioned three examples of retroele-
ment involvement in cell functions do not cover the full
Figure 2 Examples of retroelement regulation and its ability to regulate other genes. Protein products are encircled. Syncytin 1 gene
corresponding to endogenous retroviral structure is presented in two parts. The left covers the retroviral sequence and the right part depicts
retroviral envelope gene (env). For explanation see text.
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extent of their activities. There is growing evidence that
retroelements take part in the control of gene expres-
sion. Evidence has been presented showing significantly
increased retroelement representation in the promoter
region of genes, especially those involved in develop-
ment, cell differentiation and transcription regulation,
and also in additional structures delineating functional
genes such as locus control regions (LCR) or insulators
acting as a divide of individual enhancer. The sphere of
influences was reviewed by King Jordan et al., 2003[19];
Lowe et al., 2007[20]. Thus, to understand gene regula-
tion, we must take into account also retroelements.
Of special interest is the evolution of retroelements
and their role in the constitution of new important cell
functions. The evolutionary role of retroelements is
strongly supported by several observations documenting
that some of them have been conserved during evolu-
tion of tetrapods and therefore they should have served
functions not defined so far [21]. Needless to say many
other retroelements were probably modified to such an
extent that at present they escape identification. How-
ever, there are available some instances documenting
clearly that retroelements fulfill a key function. One of
them pertains to telomerase function, which serves for
extension of telomeric nucleotides, thus sealing gaps
arising at 5’ ends of the replicating DNA strand. In
lower multicellular organisms such as Rotifera or some
plants, telomere is extended by its annealing with retro-
poson Penelope equipped with telomere hexanucleotide
repeats, which reconstitute telomere during reverse tran-
scription [22].
Good statistical evidence is available demonstrating
that the human genome contains more Alus than the
chimp genome. More sensitive techniques provide evi-
dence for more extensive representation of retroele-
ments, namely Alu and LINE, estimated as 106
insertions in individual human genomes worldwide
[23,24]. Of special interest are the findings of retroele-
ment involvement in neural tissue differentiation. In
relation to this topic I would like to comment on the
discovery of a highly conserved SINE element (LF-SINE)
detected already in Latimeria (from Silurian period 410
million years ago), which remained at the same position
during later evolution [21]. As proven experimentally,
this element acts as an enhancer of neurodevelopmental
gene (ISL1), which is required for motor neuron differ-
entiation. Studies of microcephalin gene involved in the
establishment of human brain revealed that it became a
target of thousands of retrotransposable element inser-
tions and that these elements constitute 57% of gene
length [25,26]. Recent observations support the possibi-
lity that at least L1 retrotransposition in rat and human
neural tissues might play a role in producing functional
imprints on individual neural cells [27].
Looking at retroelements from a more general point
of view, we should consider their ability to spread not
only vertically, but also horizontally. This was encoun-
tered at first in LTR containing retroelement copies that
were shown to be transmitted among different species
of Drosophila. Similarly, LINE elements might have
been transferred between snakes and mammals [28]
Such horizontal transfers cannot be regarded only as
odd situations, because any distant species transfer pro-
vides retroelement relief from original cell control and
enables new possibilities of spreading [29].
In summary, retroelements should be taken seriously
not only as principal factors reshaping any genome, but
also as elements that due to their mobility can cause
damage contributing to the occurrence of important
diseases.
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